Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-054100)

Filing Details

Accession Number:: 0001209191-22-054100
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-10-19 17:29:22
Reporting Period:: 2022-10-17

Accepted Time:: 2022-10-19 17:29:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1841330	Pasithea Therapeutics Corp.	KTTA	Pharmaceutical Preparations (2834)	851591963

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1943013	David Delaney	C/O Concord Investment Partners Ltd. 60 St. Clair Avenue East, Suite 702 Toronto A6 M4T 1N5		No	No	No	Yes
1943018	Ltd. Ip2 Concord	C/O Concord Investment Partners Ltd. 60 St. Clair Avenue East, Suite 702 Toronto A6 M4T 1N5		No	No	No	Yes
1943046	Elderhill Corp	C/O Concord Investment Partners Ltd. 60 St. Clair Avenue East, Suite 702 Toronto A6 M4T IN5		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-10-17	1,000	$1.11	227,521	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Footnotes

The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President.
191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation.